ARMATA PHARMACEUTICALS, INC. Operating Cash Flow
ARMATA PHARMACEUTICALS, INC. (ARMP) reported Operating Cash Flow of -$14.45 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-12
- ARMATA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$8.67M.
- ARMATA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$5.78M.
- ARMATA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$6.67M.
- ARMATA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$4.30M.
- ARMATA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$25.76M.
- ARMATA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$37.55M.
- ARMATA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$47.42M.
- ARMATA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$32.48M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$8.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$14.45M 10-Q · filed 2026-08-12 | -$21.12M derived: sum of 3 quarters · filed 2026-08-12 | -$25.42M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | -$5.78M 10-Q · filed 2026-05-13 | -$12.46M derived: sum of 2 quarters · filed 2026-05-13 | -$16.75M derived: sum of 3 quarters · filed 2026-05-13 | -$23.96M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | -$6.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$10.97M derived: sum of 2 quarters · filed 2026-03-25 | -$18.18M derived: sum of 3 quarters · filed 2026-08-12 | -$25.76M 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | -$4.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$11.51M derived: sum of 2 quarters · filed 2026-08-12 | -$19.09M 10-Q · filed 2025-11-12 | -$27.02M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | -$7.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$14.79M 10-Q · filed 2026-08-12 | -$22.72M derived: sum of 3 quarters · filed 2026-08-12 | -$31.58M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | -$7.58M 10-Q · filed 2026-05-13 | -$15.51M derived: sum of 2 quarters · filed 2026-05-13 | -$24.37M derived: sum of 3 quarters · filed 2026-05-13 | -$34.55M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | -$7.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$16.79M derived: sum of 2 quarters · filed 2026-03-25 | -$26.97M derived: sum of 3 quarters · filed 2026-03-25 | -$37.55M 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | -$8.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$19.04M derived: sum of 2 quarters · filed 2025-11-12 | -$29.62M 10-Q · filed 2025-11-12 | -$37.73M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | -$10.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$20.76M 10-Q · filed 2025-08-12 | -$28.87M derived: sum of 3 quarters · filed 2025-08-12 | -$38.55M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | -$10.58M 10-Q · filed 2025-05-14 | -$18.69M derived: sum of 2 quarters · filed 2025-05-14 | -$28.38M derived: sum of 3 quarters · filed 2025-05-14 | -$40.44M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | -$8.11M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | -$17.79M derived: sum of 2 quarters · filed 2025-03-21 | -$29.85M derived: sum of 3 quarters · filed 2025-03-21 | -$47.42M 10-K · filed 2025-03-21 | ||||
| 2023-09-30 | -$9.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$21.75M derived: sum of 2 quarters · filed 2024-11-13 | -$39.32M 10-Q · filed 2024-11-13 | -$49.80M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | -$12.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$29.63M 10-Q · filed 2024-08-13 | -$40.12M derived: sum of 3 quarters · filed 2024-08-13 | -$50.45M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | -$17.57M 10-Q · filed 2024-05-07 | -$28.05M derived: sum of 2 quarters · filed 2024-05-07 | -$38.39M derived: sum of 3 quarters · filed 2024-05-07 | -$46.54M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | -$10.48M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$20.82M derived: sum of 2 quarters · filed 2024-03-21 | -$28.97M derived: sum of 3 quarters · filed 2024-03-21 | -$32.48M 10-K · filed 2024-03-21 | ||||
| 2022-09-30 | -$10.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$18.48M derived: sum of 2 quarters · filed 2023-11-14 | -$22.00M 10-Q · filed 2023-11-14 | -$30.59M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$8.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$11.66M 10-Q · filed 2023-08-14 | -$20.26M derived: sum of 3 quarters · filed 2023-08-14 | -$25.23M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$3.52M 10-Q · filed 2023-05-11 | -$12.11M derived: sum of 2 quarters · filed 2023-05-11 | -$17.08M derived: sum of 3 quarters · filed 2023-05-11 | -$21.61M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$8.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$13.56M derived: sum of 2 quarters · filed 2023-03-16 | -$18.10M derived: sum of 3 quarters · filed 2023-03-16 | -$23.57M 10-K · filed 2023-03-16 | ||||
| 2021-09-30 | -$4.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$9.50M derived: sum of 2 quarters · filed 2022-11-09 | -$14.98M 10-Q · filed 2022-11-09 | -$21.28M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | -$4.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$10.01M 10-Q · filed 2022-08-11 | -$16.32M derived: sum of 3 quarters · filed 2022-08-11 | -$20.20M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | -$5.47M 10-Q · filed 2022-05-12 | -$11.78M derived: sum of 2 quarters · filed 2022-05-12 | -$15.66M derived: sum of 3 quarters · filed 2022-05-12 | -$19.51M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$6.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$10.18M derived: sum of 2 quarters · filed 2022-03-17 | -$14.04M derived: sum of 3 quarters · filed 2022-03-17 | -$18.27M 10-K · filed 2022-03-17 | ||||
| 2020-09-30 | -$3.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$7.74M derived: sum of 2 quarters · filed 2021-11-10 | -$11.97M 10-Q · filed 2021-11-10 | -$14.70M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | -$3.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$8.09M 10-Q · filed 2021-08-12 | -$10.82M derived: sum of 3 quarters · filed 2021-08-12 | -$15.38M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | -$4.23M 10-Q · filed 2021-05-13 | -$6.96M derived: sum of 2 quarters · filed 2021-05-13 | -$11.53M derived: sum of 3 quarters · filed 2021-05-13 | -$17.36M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$7.30M derived: sum of 2 quarters · filed 2021-03-18 | -$13.12M derived: sum of 3 quarters · filed 2021-03-18 | -$15.58M 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | -$4.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$10.39M derived: sum of 2 quarters · filed 2020-11-12 | -$12.85M 10-Q · filed 2020-11-12 | -$16.05M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | -$5.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$8.29M 10-Q · filed 2020-08-13 | -$11.48M derived: sum of 3 quarters · filed 2020-08-13 | -$13.50M derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | -$2.46M 10-Q · filed 2020-05-14 | -$2.62M 10-Q · filed 2019-05-06 | -$5.65M derived: sum of 2 quarters · filed 2020-05-14 | -$7.67M derived: sum of 3 quarters · filed 2020-05-14 | -$9.55M derived: sum of 4 quarters · filed 2020-05-14 | |||
| 2018-12-31 | -$3.19M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | -$5.21M derived: sum of 2 quarters · filed 2020-03-19 | -$7.09M derived: sum of 3 quarters · filed 2020-03-19 | -$10.63M 10-K · filed 2020-03-19 | -$9.38M 10-K · filed 2019-03-25 | |||
| 2018-09-30 | -$2.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$3.90M derived: sum of 2 quarters · filed 2019-11-12 | -$7.43M 10-Q · filed 2019-11-12 | -$6.95M 10-Q · filed 2018-11-08 | -$9.80M derived: sum of 4 quarters · filed 2019-11-12 | |||
| 2018-06-30 | -$1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$5.41M 10-Q · filed 2019-08-14 | -$5.71M 10-Q · filed 2018-08-09 | -$7.78M derived: sum of 3 quarters · filed 2019-08-14 | -$8.37M derived: sum of 4 quarters · filed 2019-08-14 | |||
| 2018-03-31 | -$3.54M 10-Q · filed 2019-05-06 | -$5.91M derived: sum of 2 quarters · filed 2019-05-06 | -$6.50M derived: sum of 3 quarters · filed 2019-05-06 | -$9.43M derived: sum of 4 quarters · filed 2019-05-06 | ||||
| 2017-12-31 | -$2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | -$2.96M derived: sum of 2 quarters · filed 2019-03-25 | -$5.89M derived: sum of 3 quarters · filed 2019-03-25 | -$9.19M 10-K · filed 2019-03-25 | ||||
| 2017-09-30 | -$593.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$3.52M derived: sum of 2 quarters · filed 2018-11-08 | -$6.82M 10-Q · filed 2018-11-08 | |||||
| 2017-06-30 | -$2.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$6.23M 10-Q · filed 2018-08-09 | ||||||
| 2017-03-31 | -$3.30M 10-Q · filed 2018-05-15 | |||||||
| 2016-12-31 | -$10.61M 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |